Mevaseret Zion, Israel

Israel Vlodavsky

USPTO Granted Patents = 33 

 

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 235(Granted Patents)


Location History:

  • Mevaseret Zion 90805, IL (1999)
  • 90805 Mevaseret Zion, IL (2000)
  • Zion, IL (2001 - 2003)
  • Meraseret Zion, IL (2003)
  • Mevaseret Zion, IL (1999 - 2016)
  • Mevasseret Zion, IL (2010 - 2021)

Company Filing History:

goldMedal9 out of 169 
 
Hadasit Medical Research Services and Development Ltd.
 patents
silverMedal7 out of 11 
 
Insight Biopharmaceuticals Ltd.
 patents
bronzeMedal5 out of 31 
 
Hadasit Medical Research Services and Development Company
 patents
44 out of 945 
 
Technion Research & Development Foundation Limited
 patents
53 out of 4 
 
Agricultural Research Organization Ministry of Agriculture
 patents
61 out of 1 
 
Agricultural Research Org. Ministry of Agriculture (gov.)
 patent
71 out of 1 
 
Hadasitmedical Research Serv. & Devel. Ltd.
 patent
81 out of 1 
 
Agricultural Organization Ministry of Agriculture State of Israel
 patent
91 out of 1 
 
Insight Biopharmacenticals Ltd.
 patent
101 out of 7 
 
Insight Strategy Marketing Ltd.
 patents
111 out of 34 
 
Rappaport Family Institute for Research in the Medical Sciences
 patents
121 out of 60 
 
Compugen Ltd. Corporation
 patents
131 out of 1 
 
Shenzhen Hepalink Pharmaceutical Co., Ltd.
 patent
141 out of 44 
 
Carmel—haifa University Economic Corp Ltd.
 patents
1511 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2021

Loading Chart...
Loading Chart...
33 patents (USPTO):Explore Patents

Title: **Israel Vlodavsky: Pioneering Innovations in Therapeutics**

Introduction

Israel Vlodavsky, a prominent inventor located in Mevaseret Zion, Israel, holds an impressive portfolio of 33 patents. His groundbreaking contributions primarily focus on innovative medical therapies, particularly relating to heparanase activity, which has critical implications for various diseases.

Latest Patents

Among his latest inventions, Vlodavsky has developed heparanase-neutralizing monoclonal antibodies. This particular invention involves pharmaceutical compositions intended for treating diseases linked to heparanase activity, including cancer, inflammation, and diabetes, along with associated complications. Furthermore, he proposes combined therapies utilizing these antibodies alongside conventional cancer treatments, such as chemotherapy or radiation, aiming to enhance the efficacy of treatments for proliferative diseases.

His work also includes a patent on heparanase splice variants, where he explores diagnostic kits and therapeutic agents derived from these variants, along with their potential uses. This innovation represents a significant advancement in the field, providing new avenues for treatment and diagnosis.

Career Highlights

Throughout his career, Israel Vlodavsky has been associated with Hadasit Medical Research Services and Development Ltd. His work at this esteemed institution has allowed him to advance his research and contribute to the field of medical innovation significantly.

Collaborations

Vlodavsky has collaborated with notable colleagues, including Iris Pecker and Arnon Nagler, both of whom have played vital roles in his research initiatives. These collaborations have facilitated the sharing of knowledge and expertise, driving forward their collective vision for improved therapeutic options.

Conclusion

Israel Vlodavsky continues to be an influential figure in the realm of medical innovations, with his patents paving the way for future discoveries and treatments. His commitment to advancing medical science underscores the importance of innovation in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…